ITabMed

Shanghai, China · Founded 2021 · Privately Held (backing)

Developer of immunotherapy drugs for treatment of cancer. ITabMed is based in Shanghai, China and was founded in 2021. It has raised $20 million.

Last price · $/share
—
Implied valuation
—
Total raised
$20.0M
Last round
—

Who backs ITabMed?

5 investors
InvestorType
Changxing FundOther
3E Bioventures CapitalVenture capital
Peak Valley CapitalGrowth equity
Yongjin GroupOther
Binhai Venture Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ITabMed investors

5 investors are on record for ITabMed, including Changxing Fund, 3E Bioventures Capital, Peak Valley Capital and Yongjin Group.

Free account
More of ITabMed with a free account
  • ·Watch ITabMed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like ITabMed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View